Shares of the contact lens and eye\u002Dcare company climbed as much as 7.9%
With the spinoff, Joseph Papa has moved from chief executive officer of Bausch Health to CEO and chairman of Bausch + Lomb. Thomas Appio has been appointed to replace him as the top executive at Bausch Health, according to a statement. Papa will remain chairman of Bausch Health.
Bausch + Lomb, which began as an optical goods shop in 1853, was bought by Bausch Health — then known as Valeant Pharmaceuticals International Inc. — for US$8.7 billion in 2013 from an investors group that included Warburg Pincus.Article content
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: